Eurofins Supports SARS-CoV-2 Analysis Needs in the U.S.A and in Europe
Eurofins, a global leader in testing and laboratory services, announced that two of its clinical diagnostic testing laboratories in the United States now offer testing for evaluation of COVID-19.
Viracor Eurofins, one of the largest and most recognized infectious diseases testing laboratories in the U.S.A., is launching a stand-alone real time reverse transcriptase PCR assay for the qualitative detection of SARS-CoV-2. Diatherix Eurofins expects to begin testing for SARS-CoV-2 as part of its newly updated Target Enriched Multiplex PCR (TEM-PCR) Respiratory Viral Panels. Both laboratories shall offer testing in accordance with the FDA Emergency Use Authorization Guidance.
In Germany, Eurofins GeLaMed started testing for COVID-19 last week and has already tested hundreds of samples. Eurofins’ laboratories in France, the Benelux and Spain are getting ready to start testing immediately with tests they developed and validated, after approval by public health authorities which is expected shortly.
For more information, please visit www.eurofins.com